James Molloy
Stock Analyst at Alliance Global Partners
(0.78)
# 2,936
Out of 4,496 analysts
32
Total ratings
32.14%
Success rate
-39.12%
Average return
Main Sectors:
22 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PED PEDEVCO | Initiates: Buy | $1.75 | $1.04 | +68.27% | 1 | Jul 17, 2024 | |
| PXS Pyxis Tankers | Initiates: Buy | $10 | $5.16 | +93.80% | 1 | Jul 17, 2024 | |
| IGC IGC Pharma | Initiates: Buy | $3.5 | $0.46 | +660.87% | 1 | Jul 17, 2024 | |
| ALIM Alimera Sciences | Downgrades: Neutral | n/a | $5.57 | - | 3 | Jun 25, 2024 | |
| CHRO Chromocell Therapeutics | Initiates: Buy | n/a | $1.11 | - | 1 | Jun 18, 2024 | |
| OCUP Ocuphire Pharma | Maintains: Buy | $24 → $20 | $1.99 | +905.03% | 2 | Mar 20, 2024 | |
| XRTX XORTX Therapeutics | Maintains: Buy | $9 → $14 | $1.74 | +704.60% | 2 | Jan 4, 2024 | |
| SYBX Synlogic | Initiates: Buy | $30 | $1.55 | +1,835.48% | 1 | Dec 11, 2023 | |
| TNXP Tonix Pharmaceuticals Holding | Maintains: Buy | $576 → $256 | $0.56 | +45,597.97% | 6 | Aug 1, 2023 | |
| NRSN NeuroSense Therapeutics | Initiates: Buy | $7.5 | $0.73 | +931.78% | 1 | Jul 17, 2023 | |
| ABEO Abeona Therapeutics | Reiterates: Buy | $20 | $5.11 | +291.39% | 1 | May 24, 2023 | |
| SLS SELLAS Life Sciences Group | Maintains: Buy | $14 → $8 | $1.11 | +620.72% | 1 | Nov 15, 2022 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $10 → $7 | $3.20 | +118.75% | 2 | Nov 4, 2022 | |
| AKTX Akari Therapeutics, | Initiates: Buy | $80 | $3.53 | +2,166.29% | 1 | Nov 1, 2022 | |
| RVPH Reviva Pharmaceuticals Holdings | Initiates: Buy | $16 | $1.05 | +1,423.81% | 1 | Nov 1, 2022 | |
| ACXP Acurx Pharmaceuticals | Initiates: Buy | $14 | $2.43 | +476.13% | 1 | Oct 20, 2022 | |
| IMNN Imunon | Initiates: Buy | $15 | $1.25 | +1,100.00% | 1 | Oct 13, 2022 | |
| QNRX Quoin Pharmaceuticals | Initiates: Buy | $240 | $0.62 | +38,609.68% | 1 | Sep 7, 2022 | |
| CELU Celularity | Initiates: Buy | $150 | $3.02 | +4,866.89% | 1 | Aug 25, 2022 | |
| ENVB Enveric Biosciences | Initiates: Buy | $63 | $0.47 | +13,197.87% | 1 | Jun 1, 2022 | |
| AMPE Ampio Pharmaceuticals | Initiates: Buy | $1,350 | $0.04 | +3,374,900.00% | 1 | Mar 24, 2022 | |
| ACHV Achieve Life Sciences | Initiates: Buy | n/a | $4.63 | - | 1 | Oct 4, 2021 |
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $1.75
Current: $1.04
Upside: +68.27%
Pyxis Tankers
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $5.16
Upside: +93.80%
IGC Pharma
Jul 17, 2024
Initiates: Buy
Price Target: $3.5
Current: $0.46
Upside: +660.87%
Alimera Sciences
Jun 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.57
Upside: -
Chromocell Therapeutics
Jun 18, 2024
Initiates: Buy
Price Target: n/a
Current: $1.11
Upside: -
Ocuphire Pharma
Mar 20, 2024
Maintains: Buy
Price Target: $24 → $20
Current: $1.99
Upside: +905.03%
XORTX Therapeutics
Jan 4, 2024
Maintains: Buy
Price Target: $9 → $14
Current: $1.74
Upside: +704.60%
Synlogic
Dec 11, 2023
Initiates: Buy
Price Target: $30
Current: $1.55
Upside: +1,835.48%
Tonix Pharmaceuticals Holding
Aug 1, 2023
Maintains: Buy
Price Target: $576 → $256
Current: $0.56
Upside: +45,597.97%
NeuroSense Therapeutics
Jul 17, 2023
Initiates: Buy
Price Target: $7.5
Current: $0.73
Upside: +931.78%
Abeona Therapeutics
May 24, 2023
Reiterates: Buy
Price Target: $20
Current: $5.11
Upside: +291.39%
SELLAS Life Sciences Group
Nov 15, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $1.11
Upside: +620.72%
Aquestive Therapeutics
Nov 4, 2022
Maintains: Buy
Price Target: $10 → $7
Current: $3.20
Upside: +118.75%
Akari Therapeutics,
Nov 1, 2022
Initiates: Buy
Price Target: $80
Current: $3.53
Upside: +2,166.29%
Reviva Pharmaceuticals Holdings
Nov 1, 2022
Initiates: Buy
Price Target: $16
Current: $1.05
Upside: +1,423.81%
Acurx Pharmaceuticals
Oct 20, 2022
Initiates: Buy
Price Target: $14
Current: $2.43
Upside: +476.13%
Imunon
Oct 13, 2022
Initiates: Buy
Price Target: $15
Current: $1.25
Upside: +1,100.00%
Quoin Pharmaceuticals
Sep 7, 2022
Initiates: Buy
Price Target: $240
Current: $0.62
Upside: +38,609.68%
Celularity
Aug 25, 2022
Initiates: Buy
Price Target: $150
Current: $3.02
Upside: +4,866.89%
Enveric Biosciences
Jun 1, 2022
Initiates: Buy
Price Target: $63
Current: $0.47
Upside: +13,197.87%
Ampio Pharmaceuticals
Mar 24, 2022
Initiates: Buy
Price Target: $1,350
Current: $0.04
Upside: +3,374,900.00%
Achieve Life Sciences
Oct 4, 2021
Initiates: Buy
Price Target: n/a
Current: $4.63
Upside: -